Therefore, Ikaros exerts an antioncogenic role, mediated through the repression of some targets involved in cell cycle progression (e.g., CDC2 and CDC7), that counteracts EZH2 loss-of-function in BCP-ALL [44]. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.